[1] Liang CC, Huang TJ, Yang SH, et al. Prevention of catheter-associated urinary tract infection in neurological post-operation patients: a best practice implementation project[J]. JBI Database System Rev Implement Rep, 2019, 17(6):1256-1267. DOI: 10.11124/JBISRIR-2017-003945.
[2] 陈亚平,魏红,方静,等.神经外科导管滑脱危险因素分析与预见性护理干预[J].西南国防医药,2019,29(6):702-703. DOI:10.3969/j.issn.1004-0188.2019.06.026.
[3] 邓瑛瑛,裴华清,文梅,等.神经外科重症患者PICC相关性血栓物理预防的最佳证据总结[J].护理学报,2021,28(8):28-32. DOI:10.16460/j.issn1008-9969.2021.08.028.
1-特异度
[4] Kim YO, Chung CR, Gil E, et al. Safety and feasibility of ultrasound-guided placement of peripherally inserted central catheter performed by neurointensivist in neurosurgery intensive care unit[J]. PLoS One, 2019, 14(5):e0217641. DOI: 10.1371/journal.pone.0217641.
[5] 朱颖,赵燕,周燕妮,等.外周中等长度导管在神经外科患者中的应用效果[J].实用临床医药杂志,2021,25(2):40-42,58. DOI:10.7619/jcmp.20200754.
[6] 杨婷,李迎霞,王晨钟,等.神经外科中心静脉导管相关血流感染病原学及死亡危险因素[J].中华医院感染学杂志,2021,31(1):86-90. DOI:10.11816/cn.ni.2021-201900.
[7] Brandmeir NJ, Davanzo JR, Payne R, et al. A randomized trial of complications of peripherally and centrally inserted central lines in the neuro-intensive care unit: results of the NSPVC trial[J]. Neurocrit Care, 2020, 32(2):400-406. DOI: 10.1007/s12028-019-00843-z.
[8] Toor H, Farr S, Savla P, et al. Prevalence of central line-associated bloodstream infections (CLABSI) in intensive care and medical-surgical units[J]. Cureus, 2022, 14(3):e22809. DOI: 10.7759/cureus.22809.
[9] Gorski LA. The 2016 infusion therapy standards of practice[J]. Home Healthc Now, 2017, 35(1):10-18. DOI: 10.1097/NHH.0000000000000481.
[10] Nickel B. Peripheral intravenous access: applying infusion therapy standards of practice to improve patient safety[J]. Crit Care Nurse, 2019, 39(1):61-71. DOI: 10.4037/ccn2019790.
[11] 伊秋香,伊秀英,周若霞,等.改良型中等长度导管在肝胆胰患者中的应用研究[J].赣南医学院学报,2021,41(4):396-398. DOI:10.3969/j.issn.1001-5779.2021.04.016.
[12] 陈香.改良型中等长度导管与PICC在胃肠道肿瘤患者围手术期中的应用比较[J].当代临床医刊,2021,34(4):60,77. DOI:10.3969/j.issn.2095-9559.2021.04.041.
[13] 胡爱珍,喻燕敏.改良型三向瓣膜式中等长度导管在老年患者中的应用[J].中国老年保健医学,2019,17(4):120-122. DOI:10.3969/j.issn.1672-2671.2019.04.045.
[14] 屈媛媛,孙艳.改良三向瓣膜式中长导管在神经重症患者中的应用与护理[J].天津护理,2020,28(5):593-595. DOI:10.3969/j.issn.1006-9143.2020.05.028.
[15] Zhao Y, Geng J, Wu X, et al. Safety of locating the tip of a medium-long catheter at the axillary front and clavicle midline: a protocol for systematic review and meta-analysis[J]. Medicine (Baltimore), 2020, 99(50):e23726. DOI: 10.1097/MD.0000000000023726.
[16] 赵玉桃,朱健,成雪芹.集束化干预降低神经外科PICC置管异位率的效果[J].实用临床医药杂志,2018,22(12):65-68. DOI:10.7619/jcmp.201812019.
[17] 邱琴,符代雪,詹丽,等.腔内心电图定位联合颈内静脉阻断法在神经外科PICC置管中的应用[J].中国实用神经疾病杂志,2018,21(15):1736-1740. DOI:10.12083/SYSJ.2018. 15.399.
[18] 吴莉,贾仕群.半卧位配合深吸气时送入PICC对预防导管异位的效果观察[J].检验医学与临床,2020,17(16):2382-2384. DOI:10.3969/j.issn.1672-9455.2020.16.036.
[19] 倪云,罗志华,张琳.不同颈部静脉阻断法预防PICC置管导管异位的价值比较[J].国际护理学杂志,2020,39(6):1051-1053. DOI:10.3760/cma.j.cn221370-20180620- 00321.
[20] Smith T, Kaufman C, Quencer K. Internal jugular central venous catheter tip migration: patient and procedural factors[J]. Tomography, 2022, 8(2):1033-1040. DOI: 10.3390/tomography8020083.
[21] 廖招娣,王洪干,林征,等.PICC中心静脉置管双层保护套在神经外科危重患者中的应用[J].护理学报,2019,26(11):71-73. DOI:10.16460/j.issn1008-9969.2019.11.071.
[22] 李佩兰,李玉珠,赵翠兰,等.超声引导下结合改良塞丁格技术置入PICC导管在慢性老年患者中的临床应用[J].国际医药卫生导报,2018,24(15):2291-2294. DOI:10.3760/cma.j.issn.1007-1245.2018.15.020.
[23] Kim YI, Ryu JH, Min MK, et al. Usefulness of ultrasonography for the evaluation of catheter misplacement and complications after central venous catheterization[J]. Clin Exp Emerg Med, 2018, 5(2):71-75. DOI: 10.15441/ceem.16.189.
[24] 陈竹梅,华月英,温艳艳,等.行超声引导下PICC置管患者并发症的发生情况及影响因素[J].昆明医科大学学报,2021,42(2):173-178. DOI:10.12259/j.issn.2095-610X.S20210209.
[25] 王昕,赵晓虹,巫浣玲.PICC导管异位相关因素及预防措施的研究[J].中国医疗器械信息,2019,25(24):7-8. DOI:10.3969/j.issn.1006-6586.2019.24.004.
[26] 黄世英.PICC置管时导管异位至颈静脉的原因分析及见策[J].齐齐哈尔医学院学报,2017,38(3):345-347. DOI:10.3969/j.issn.1002-1256.2017.03.046.
[27] 陈银玲,李超,张小东,等.乳腺癌化疗患者经外周静脉穿刺的中心静脉导管置管中导管异位的影响因素[J].癌症进展,2021,19(21):2249-2251,2264. DOI:10.11877/j.issn.1672-1535.2021.19.21.25.
[28] 谢彩英,许雪梅,杜丽群,等.改良型中等长度导管在HIV/AIDS患者中的临床应用[J].现代医药卫生,2021,37(24):4277-4282. DOI:10.3969/j.issn.1009-5519.2021.24.037.
[29] 边春鸽,陈施清.经外周中心静脉置管继发性异位原因分析及对策[J].浙江临床医学,2020,22(1):62-63.
[30] 廖利萍,王科,陈英,等.经外周静脉穿刺中心静脉置入术导管异位的影响因素[J].局解手术学杂志,2020,29(3):231-234. DOI:10.11659/jjssx.12E019117.
[31] 宋慧.改良送管法在预防PICC置管异位中的应用研究[J].护士进修杂志,2019,34(22):2088-2089. DOI:10.16821/j.cnki.hsjx.2019.22.019.
[32] 武晓,侯晓丽,李瑞英.基于集束化管理的健康宣教联合心理疏导在PICC导管相关性感染患者中的应用观察[J].哈尔滨医药,2021,41(2):125-126.
|